Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

0 Class I (most serious) drug recalls reported in the last 30 days.

3,222 recalls

  • Class II Ongoing

    Sermorelin Lyophilized powder for reconstitution, 10mg, Vial capacity 10 mL Multi-Dose, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    Lot#: GG062425-002 within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0090-2026
  • Class II Ongoing

    Epithalon for Injection, 20mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692 manufactured for Extension Health.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    Lot#: GG053025-002 within expiry
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0089-2026
  • Class II Ongoing

    Tesamorelin for Injection, 15mg, 10 mL Multi-Dose Vial, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    Lot#: GG020425-004 within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0088-2026
  • Class II Ongoing

    Thymosin Beta-4 (TB4) for Injection, 15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    Lot#: GG060525-001 within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0087-2026
  • Class II Ongoing

    BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension…

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).
    Lots / codes
    Lot#: GG020525-001, GG060525-001, GG062625-004, within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0086-2026
  • Class II Ongoing

    BPC-157 for Injection, 15mg/10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 15mg, 10mL vial lyophilized.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    BPC-157 for Injection, 15mg/10mL vial, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 15mg, 10mL vial lyophilized.
    Lots / codes
    Lot#: GG012825-002 within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0085-2026
  • Class II Ongoing

    Zinc Chloride for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0084-2026
  • Class II Ongoing

    Semaglutide with B12 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0083-2026
  • Class II Ongoing

    Sterile Saline Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0082-2026
  • Class II Ongoing

    Reconstitution XO Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health a) 5% Exosomes, 10 mL vial and b…

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    Reconstitution XO Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health a) 5% Exosomes, 10 mL vial and b) 10% Exosomes, 5 mL vial, Extension Health a) 20% Exosomes, 10 mL vial, b) 10% Exosomes, 10 mL vial and Medical Health Institute (MHI), a) 10 % Exosomes, 2mL vial, 5mL vial, 10mL vial, b) 5% Exosomes, 2mL vial, 5mL vial, 10mL vial.
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0081-2026
  • Class II Ongoing

    pH Buffered Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 10mL…

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    pH Buffered Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Medical Health Institute (MHI), 10mL.
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0080-2026
  • Class II Ongoing

    Proline for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0079-2026
  • Class II Ongoing

    Pentosan for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0078-2026
  • Class II Ongoing

    Oxytocin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0077-2026
  • Class II Ongoing

    Low Solubility Peptide Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.Also labeled as manufactured for CELIA Health.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0076-2026
  • Class II Ongoing

    Elite Stack Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Medical Health…

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    Elite Stack Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health and Medical Health Institute (MHI).
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0075-2026
  • Class II Ongoing

    Elite Stack MSC Exosome Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health, a) 22…

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Product
    Elite Stack MSC Exosome Reconstitution Solution for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for Extension Health, a) 22 billion per vial, 8mL of solution in 10mL vial, b) 44 billion per vial, 8mL of solution in 10mL vial.
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0074-2026
  • Class II Ongoing

    EDTA for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0073-2026
  • Class II Ongoing

    CoQ10 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0072-2026
  • Class II Ongoing

    Cerebrolysin for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    —
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0071-2026
  • Class II Ongoing

    Zinc Sulfate for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    467
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0070-2026
  • Class II Ongoing

    Vitamin D3 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    339
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0069-2026
  • Class II Ongoing

    Ultra Burn for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    12
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0068-2026
  • Class II Ongoing

    Tri-Immune for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    166
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0067-2026
  • Class II Ongoing

    Taurine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

    Reason: Lack of Assurance of Sterility

    GenoGenix LLC

    Lots, distribution and details
    Lots / codes
    All lots within expiry.
    Distribution
    US Nationwide.
    Quantity
    294
    Recall started
    July 30, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0066-2026

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update November 2, 2026 02:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement